A phase I study to evaluate the efficacy and safety of MVA-BN RSV vaccine in paediatric patients

Trial Profile

A phase I study to evaluate the efficacy and safety of MVA-BN RSV vaccine in paediatric patients

Planning
Phase of Trial: Phase I

Latest Information Update: 26 May 2016

At a glance

  • Drugs MVA-BN RSV (Primary)
  • Indications Respiratory syncytial virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 26 May 2016 New trial record
    • 23 May 2016 According to a Bavarian Nordic media release, the company plans to initiate this trial in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top